These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 1833309)

  • 21. A threshold effect in the induction of tumorigenicity of an established human cell line by v-mos.
    O'Hara BM; Blair DG
    Oncogene; 1988 Sep; 3(3):295-9. PubMed ID: 2974527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Accumulation of the c-mos protein is correlated with post-natal development of skeletal muscle.
    Leibovitch SA; Guillier M; Lenormand JL; Leibovitch MP
    Oncogene; 1991 Sep; 6(9):1617-22. PubMed ID: 1833718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of specific transformation-associated proteins (TAPs) in two rat cell lines is closely related to the expression of the v-mos gene product of Moloney murine sarcoma virus (Mo-MSV).
    Li W; Bowen JM; Chan JC
    Intervirology; 1987; 28(1):50-6. PubMed ID: 2828268
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The production and characterisation of monoclonal antibodies to myc, c-erbB-2 and EFG-receptor using a synthetic peptide approach.
    Price KM; Cuthbertson AS; Varndell IM; Sheppard PW
    Dev Biol Stand; 1990; 71():23-31. PubMed ID: 1698166
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The proteins encoded by c-akt and v-akt differ in post-translational modification, subcellular localization and oncogenic potential.
    Ahmed NN; Franke TF; Bellacosa A; Datta K; Gonzalez-Portal ME; Taguchi T; Testa JR; Tsichlis PN
    Oncogene; 1993 Jul; 8(7):1957-63. PubMed ID: 8510938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. v-mos-transformed cells fail to enter quiescence but growth arrest in G1 following serum withdrawal.
    Rhodes N; Hicks R; Kasenally AB; Innes CL; Paules RS; Propst F
    Exp Cell Res; 1994 Jul; 213(1):210-7. PubMed ID: 8020593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated expression of v-mos is correlated with altered differentiation of carcinoma cells.
    Scherdin U; Steffen M; Dietel M; Boecker W; Breindl M; Hölzel F
    Oncogene; 1990 Nov; 5(11):1619-27. PubMed ID: 2148370
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The v-mos and c-Ha-ras oncoproteins exert similar effects on the pattern of protein synthesis.
    Klemenz R; Hoffmann S; Jaggi R; Werenskiold AK
    Oncogene; 1989 Jun; 4(6):799-803. PubMed ID: 2525241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epidermal growth factor precursor is related to the translation product of the Moloney sarcoma virus oncogene mos.
    Baldwin GS
    Proc Natl Acad Sci U S A; 1985 Apr; 82(7):1921-5. PubMed ID: 2984673
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle-mediated structural and functional alteration of P85gag-mos protein kinase activity.
    Liu JX; Singh B; Wlodek D; Arlinghaus RB
    Oncogene; 1990 Feb; 5(2):171-8. PubMed ID: 2138725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential transformation of C3H10T1/2 cells by v-mos: sequential expression of transformation parameters.
    van der Hoorn FA; Müller V
    Mol Cell Biol; 1985 Sep; 5(9):2204-11. PubMed ID: 3016522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinase activities of c-Mos and v-Mos proteins: a single amino acid exchange is responsible for constitutive activation of the 124 v-Mos kinase.
    Puls A; Proikas-Cezanne T; Marquardt B; Propst F; Stabel S
    Oncogene; 1995 Feb; 10(4):623-30. PubMed ID: 7862439
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of metal-induced mutations altering the expression or structure of a retroviral gene in a mammalian cell line.
    Biggart NW; Murphy EC
    Mutat Res; 1988 Mar; 198(1):115-29. PubMed ID: 2832750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Use of antipeptide antibodies to probe the catalytic activity of p37v-mos.
    Singh B; al-Bagdadi F; Liu JX; Arlinghaus RB
    Virology; 1990 Oct; 178(2):535-42. PubMed ID: 2171192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of v-mos Ser 47 by the mitotic form of p34cdc2.
    Bai WL; Singh B; Karshin WL; Shonk RA; Arlinghaus RB
    Oncogene; 1991 Oct; 6(10):1715-23. PubMed ID: 1833715
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of mos oncogene product in Swiss 3T3 cells induces apoptosis preferentially during S-phase.
    Fukasawa K; Rulong S; Resau J; Pinto da Silva P; Vande Woude GF
    Oncogene; 1995 Jan; 10(1):1-8. PubMed ID: 7824263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mouse c-mos oncogene activation is prevented by upstream sequences.
    Wood TG; McGeady ML; Baroudy BM; Blair DG; Vande Woude GF
    Proc Natl Acad Sci U S A; 1984 Dec; 81(24):7817-21. PubMed ID: 6096859
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Presence and possible role of c-ras and nuclear (c-fos and c-jun) proto-oncogene products in preimplantation embryonic development in mice.
    Ahmad K; Naz RK
    Mol Reprod Dev; 1993 Nov; 36(3):297-306. PubMed ID: 8286110
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Preparation and characterization of monoclonal antibody against HCCR protein].
    Liu BC; Huo JR; Liu YF; Fan GC; Wang QM
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Oct; 27(10):1094-7. PubMed ID: 21968311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recognition of mos-related proteins with an antiserum to a peptide of the v-mos gene product.
    Gallick GE; Sparrow JT; Singh B; Maxwell SA; Stanker LH; Arlinghaus RB
    J Gen Virol; 1985 May; 66 ( Pt 5)():945-55. PubMed ID: 2987403
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.